AI-driven epitope screening accelerates vaccine design but risks reinforcing extractive biomedical paradigms over systemic immune health solutions

Indigenous knowledge systems, such as those in the Amazon or Himalayas, have historically used plant-based compounds to modulate immune responses in holistic ways, often without isolating single epitopes. These traditions emphasize the interconnectedness of immune health with environment, spirituality, and community, offering alternatives to the reductionist epitope screening paradigm. The epiGPTope system, while innovative, risks erasing this wisdom by prioritizing synthetic epitope optimization over systemic immune health. Indigenous critiques of biomedical extractivism further highlight the ethical concerns of patenting immune responses.

The history of vaccine development is fraught with ethical failures, such as the Tuskegee syphilis experiments and the exploitation of Global South populations for clinical trials. The epitope screening approach echoes past reductionist paradigms, such as the early 20th-century focus on single-pathogen vaccines, which often overlooked broader immune system dynamics. The 1976 swine flu vaccine debacle, which caused mass harm due to rushed development, serves as a cautionary tale for AI-driven epitope optimization. Historical precedents also show how technological breakthroughs in medicine often serve corporate interests before public health needs.

Cross-culturally, immune health is framed differently: in Ayurveda, immunity ('ojas') is tied to digestion and mental clarity, while in traditional Chinese medicine, it is linked to 'wei qi' (defensive energy) and environmental harmony. African traditional medicine often uses polyherbal formulations to modulate immune responses, contrasting with the Western focus on single-epitope targeting. The epiGPTope system's machine learning approach risks universalizing a Western biomedical model, ignoring these diverse frameworks. However, some African and Asian researchers are now integrating traditional knowledge with AI-driven epitope screening, offering hybrid solutions.

Epitope screening is grounded in immunogenetics, where specific protein fragments (epitopes) are recognized by immune cells to trigger responses. Machine learning accelerates epitope discovery by predicting binding affinities, reducing trial-and-error in vaccine design. However, the scientific community has raised concerns about the oversimplification of immune responses, as epitopes are part of complex, dynamic networks. The epiGPTope system's reliance on synthetic data may also introduce biases, as training datasets often lack diversity in global immune profiles.

Artistic and spiritual traditions often depict immunity as a metaphor for resilience, such as the Japanese concept of 'mottainai' (waste not, want not) or the African philosophy of 'ubuntu' (I am because we are). These frameworks emphasize communal and ecological balance, contrasting with the individualistic, pathogen-focused approach of epitope screening. Indigenous art and storytelling frequently encode immune wisdom, such as the use of specific plants in healing rituals, which are absent in the epiGPTope narrative. The spiritual dimension of health is also reflected in practices like yoga or meditation, which modulate immune responses through mind-body connections.

Future scenarios for epitope screening include both utopian and dystopian outcomes: rapid vaccine development for pandemics versus the monopolization of immune data by corporations. AI-driven epitope libraries could enable personalized vaccines but may also exacerbate global health disparities if access is restricted. The integration of indigenous knowledge and decentralized AI models could democratize immune health solutions, but this requires systemic shifts in funding and policy. Climate change will also reshape immune landscapes, necessitating adaptive epitope screening strategies that account for emerging pathogens.

Marginalized communities, particularly in the Global South, are often excluded from the benefits of AI-driven biomedical innovations despite bearing the brunt of vaccine inequity. Indigenous researchers and healers, who possess critical knowledge of immune modulation, are rarely included in epitope screening collaborations. Women, who are primary caregivers and often bear the disproportionate burden of vaccine-preventable diseases, are also sidelined in the narrative. The epiGPTope system's focus on high-income markets risks deepening these inequities by prioritizing profit over global health equity.